Cargando…

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction

BACKGROUND AND OBJECTIVE: The rate of obesity is increasing in Asia, but the clinical impact of body mass index (BMI) on the outcome of chronic obstructive pulmonary disease (COPD) remains unknown. We aimed to assess this impact while focusing on the risk of exacerbation, health-care utilization, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Yong Suk, Kim, Yee Hyung, Lee, Jung Yeon, Kim, Kyungjoo, Jung, Ki-Suck, Yoo, Kwang Ha, Rhee, Chin Kook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067770/ https://www.ncbi.nlm.nih.gov/pubmed/30100716 http://dx.doi.org/10.2147/COPD.S163000

Ejemplares similares

Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications
por: Lee, Jin Hwa, et al.
Publicado: (2017)

Subtypes of Patients with Mild to Moderate Airflow Limitation as Predictors of Chronic Obstructive Pulmonary Disease Exacerbation
por: Kim, Nam Eun, et al.
Publicado: (2023)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Regular follow-up visits reduce the risk for asthma exacerbation requiring admission in Korean adults with asthma
por: Park, Hye Jung, et al.
Publicado: (2018)

Hand Grip Strength and Likelihood of Moderate-to-Severe Airflow Limitation in the General Population
por: Kim, Sunyoung, et al.
Publicado: (2022)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database
por: Lee, Hyun, et al.
Publicado: (2016)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Heterogeneity of asthma and COPD overlap
por: Kim, Min-Hye, et al.
Publicado: (2018)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study
por: Park, Hye Jung, et al.
Publicado: (2018)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
por: Kim, Tae Hoon, et al.
Publicado: (2019)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Joon Young, et al.
Publicado: (2023)

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study
por: Kim, Cheong-Ju, et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19
por: Kim, Youlim, et al.
Publicado: (2022)

Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Effect of Airflow Limitation on Acute Exacerbations in Patients with Destroyed Lungs by Tuberculosis
por: Kim, Soo Jung, et al.
Publicado: (2015)

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease
por: Joo, Dong-Hyun, et al.
Publicado: (2021)

Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations
por: Yoon, Sunyoung, et al.
Publicado: (2019)

Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Heock, et al.
Publicado: (2016)

Does the Use of Asthma-Controller Medication in Accordance with Guidelines Reduce the Incidence of Acute Exacerbations and Healthcare Costs?
por: Lee, Suh-Young, et al.
Publicado: (2022)

Increased hospitalizations and economic burden in COPD with bronchiectasis: a nationwide representative study
por: Kim, Youlim, et al.
Publicado: (2022)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease
por: Yoo, Jungmin, et al.
Publicado: (2022)

The global status of chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kef472ljlqt4cjd670fut820sl